Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00MYQ
|
||||
Former ID |
DAP000863
|
||||
Drug Name |
Protriptyline
|
||||
Synonyms |
Amimetilina; Impril; Maximed; Novopramine; Protriptilina; Protriptylinum; Protryptyline; Rhotrimine; Triptil; Triptyl; Vivactil; Vivactyl; Triptil hydrochloride; Normethyl EX4442; Triadapin 5; Apo-Imipramine; Apo-Trimip; Novo-Doxepin; Novo-Tripramine; Protriptilina [INN-Spanish]; Protriptyline (INN); Protriptyline [INN:BAN]; Protriptylinum [INN-Latin]; Vivactil (TN); N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine; N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine; N-Methyl-5H-dibenzo(a,d)cycloheptene-5-propylamine; N-3-(5H-Dibenzo(a,d)cyclohepten-5-yl)propyl-N-methylamine; 3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine; 3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine; 5-(3-Methylaminopropyl)-5H-Dibenzo[a,d]cycloheptene; 5-(3-Methylaminopropyl)-5H-dibenzo(a,d)cycloheptene; 5H-Dibenzo[a, d]cycloheptene-5-propanamine, N-methyl-, hydrochloride; 7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antidepressants
|
||||
Company |
Teva Womens Health Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H21N
|
||||
InChI |
InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3
|
||||
InChIKey |
BWPIARFWQZKAIA-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 438-60-8
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9612, 794681, 4903494, 7849630, 7980423, 8153064, 10522905, 11111679, 11111680, 11466958, 11468078, 11486755, 15221639, 29214865, 29224052, 46505128, 47291296, 47365392, 47589161, 47736675, 47736676, 47959952, 48035323, 48416494, 49699033, 49961823, 50100330, 50104299, 57322553, 78122381, 85177328, 85209617, 85787376, 90341254, 92714631, 93167175, 96025133, 103189728, 104061736, 104307929, 124750138, 124881218, 124881219, 124881220, 126623989, 127578602, 134338142, 134974679, 137001421, 142365103
|
||||
ChEBI ID |
ChEBI:8597
|
||||
SuperDrug ATC ID |
N06AA11
|
||||
SuperDrug CAS ID |
cas=000438608
|
||||
Target and Pathway | |||||
Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [537742] | |
PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
References | |||||
Ref 536306 | Emerging treatments for depression. Expert Opin Pharmacother. 2006 Dec;7(17):2323-39. | ||||
Ref 542305 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7285). | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.